Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Dendritic Spine Maturation and Morphogenesis via MicroRNA-132 Upregulation
- Atsuko Hayata-Takano1,2,*,
- Toshihiko Kamo1,*,
- Harui Kijima1,
- Kaoru Seiriki1,3,
- Katsuya Ogata1,
- Yukio Ago1,4,
- Takanobu Nakazawa1,5,
- Yusuke Shintani1,
- Kosuke Higashino1,
- Kazuki Nagayasu1,
- Norihito Shintani1,
- Atsushi Kasai1,
- James A. Waschek6, and
- Hitoshi Hashimoto1,2,7,8
- 1Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan,
- 2United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University, and University of Fukui, Osaka 565-0871, Japan,
- 3Institute for Transdisciplinary Graduate Degree Programs, Osaka University, Osaka 565-0871, Japan,
- 4Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan,
- 5Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan,
- 6Intellectual Development and Disabilities Research Center, David Geffen School of Medicine, University of California–Los Angeles, Los Angeles, California 90095,
- 7Division of Bioscience, Institute for Datability Science, Osaka University, Osaka 565-0871, Japan, and
- 8Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565–0871, Japan
-
Author contributions: A.H.-T. and H.H. designed research; A.H.-T., T.K., H.K., K.S., K.O., and Y.S. performed research; A.H.-T., T.K., K.S., and Y.A. analyzed data; A.H.-T. wrote the first draft of the paper; A.H.-T., T.N., J.A.W., and H.H. edited the paper; A.H.-T., T.N., and H.H. wrote the paper; K.S., Y.A., T.N., K.H., K.N., N.S., and A.K. contributed unpublished reagents/analytic tools.
-
↵*A.H.-T. and T.K. contributed equally to this work.
Abstract
Alterations in pituitary adenylate cyclase-activating polypeptide (PACAP), a multifunctional neuropeptide, and its receptors have been identified as risk factors for certain psychiatric disorders, including schizophrenia. Increasing evidence from human genetic and animal model studies suggest an association between various psychiatric disorders and altered dendritic spine morphology. In the present study, we investigated the role of exogenous and endogenous PACAP in spine formation and maturation. PACAP modified the density and morphology of PSD-95-positive spines in primary cultured hippocampal neurons. Notably, PACAP increased the levels of microRNA (miR)-132 and decreased expression of corresponding miR-132 target genes and protein expression of p250GAP, a miR-132 effector known to be involved in spine morphology regulation. In corroboration, PSD-95-positive spines were reduced in PACAP-deficient (PACAP−/−) mice versus WT mice. Golgi staining of hippocampal CA1 neurons revealed a reduced spine densities and atypical morphologies in the male PACAP−/− mice. Furthermore, viral miR-132 overexpression reversed the reduction in hippocampal spinal density in the male PACAP−/− mice. These results indicate that PACAP signaling plays a critical role in spine morphogenesis possibly via miR-132. We suggest that dysfunction of PACAP signaling may contribute to the pathogenesis of neuropsychiatric disorders, at least partly through its effects on spine formation.
SIGNIFICANCE STATEMENT Pituitary adenylate cyclase-activating polypeptide (PACAP) signaling dysfunction and dendritic spine morphology alterations have recently been suggested as important pathophysiological mechanisms underlying several psychiatric and neurological disorders. In this study, we investigated whether PACAP regulates dendritic spine morphogenesis. In a combination of pharmacological and viral gain- and loss-of-function approaches in vitro and in vivo experiments, we found PACAP to increase the size and density of dendritic spines via miR-132 upregulation. Together, our data suggest that a dysfunction of PACAP signaling may contribute to the pathogenesis of neuropsychiatric disorders, at least partly through abnormal spine formation.
- Received September 24, 2018.
- Revision received February 18, 2019.
- Accepted March 13, 2019.
- Copyright © 2019 the authors





